ZNG Medical
ZNG Medical
Renal Replacement Therapy (RRT)—including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy (CRRT)—serves as a life-sustaining modality for millions of patients globally suffering from acute kidney injury (AKI) and end-stage renal disease (ESRD). The manufacturing of RRT equipment, particularly consumables like vascular access systems, AV fistula needles, infusion lines, and catheter kits, demands the highest standard of engineering precision.
As a premier CE certified manufacturer, Zhejiang ZNG Medical has spent decades perfecting the production of ultra-precise medical needle structures and fluid pathways. Our products minimize clinical hazards, such as needle-induced hemolysis, thrombosis, and catheter-related bloodstream infections (CRBSIs). In high-flux blood purification, even a microscopic deviation in needle bevel geometry or inner lumen smoothness can cause turbulence, damaging cellular blood components. Therefore, our automated manufacturing plants leverage advanced siliconization processes and micrometer-level quality inspections to safeguard patients in every critical treatment session.
Founded in 1996, Zhejiang ZNG Medical has established itself as a leading global medical device enterprise. We specialize in the research, development, and high-volume production of sterile injection systems, medical needles, and RRT-associated fluid pathways. Through our strict adherence to the ISO 9001 and ISO 13485 quality systems, coupled with CE certification, we supply high-performance medical components designed to integrate seamlessly into modern clinical workflows.
Our core product lines represent the peak of medical needle design. We manufacture a comprehensive catalog of clinical needles:
The global sourcing landscape for medical devices has shifted. China’s medical supply chains, particularly in regional hubs like Zhejiang, offer unprecedented competitive advantages for distributors and hospital procurement units worldwide.
1. Complete Vertical Integration: From medical-grade stainless steel wire drawing and polymer compounding to automated assembly, sterile packaging, and EO (Ethylene Oxide) sterilization, our localized cluster model reduces transportation delays and material sourcing latency. This guarantees uninterrupted supply even during global macroeconomic shocks.
2. Strict Quality Controls and Lower Overhead: Utilizing state-of-the-art Japanese needle grinding machinery and automated optical inspection systems allows us to maintain a low defect rate (<1 ppm) while optimizing manufacturing overhead. The resulting price efficiency is directly passed to our global clients, enabling robust margins.
3. Scalable Production Capacity: With over 27 years of infrastructure development, ZNG Medical operates expansive ISO cleanrooms capable of processing high-volume monthly orders of complex consumables. This scale ensures that large-scale tenders from government health ministries or national dialysis networks are delivered on time, every time.
Procurement directors and B2B hospital suppliers evaluate medical devices on several dimensions beyond unit cost. True cost of ownership incorporates regulatory security, structural durability, and biocompatibility safety.
In the RRT segment, patient blood comes into contact with external polymer materials for extended durations (often 4 hours per hemodialysis session, 3 times a week). Buyers must ensure that all tubing, catheters, and needles are free from toxic plasticizers (DEHP-free and latex-free formulations). Our CE certification guarantees that our components meet the strict standards of the European Union Medical Device Regulation (MDR 2017/745), giving buyers complete market entry compliance and assurance against clinical liability.
Different clinical settings present distinct requirements for vascular access and fluid administration. ZNG Medical designs specialized solutions tailored for various patient profiles and environments:
During acute kidney injury (AKI) management, CRRT systems require highly stable venous catheters and arterial-venous interfaces. Our triple-lumen central venous catheter kits provide secure access paths for continuous hemodiafiltration without kinking under pressure.
High patient turnover rates require reliable, easy-to-use AV fistula needles. ZNG's ultra-thin-walled needles enable maximum blood flow rates (400-500 mL/min) with minimal puncture trauma, accelerating healing and reducing vascular access complications.
Pediatric patients have delicate vasculatures that require micro-gauge needles and soft, highly flexible catheters. ZNG specializes in custom-made microcannulas and small-gauge scalp vein sets configured to minimize pain and guard against infiltration.
Successfully launching and maintaining medical products in global markets requires extensive technical documentation. ZNG Medical supports our distributors with full regulatory backing:
We provide professional end-to-end OEM and ODM customization services for global medical brands. Our 12-step service flow guarantees that your custom needle designs and specifications are translated into certified clinical products.
The landscape of extracorporeal renal replacement therapy is evolving rapidly, driven by technological breakthroughs that enhance clinical outcomes and reduce treatment burdens. Key industry directions include:
1. Wearable and Portable Artificial Kidneys (WAK): High-efficiency dialysis is moving from massive, clinical machines to compact, portable home-use designs. For manufacturers, this shift requires specialized, lightweight tubing networks, miniaturized connection hubs, and custom microcannulas.
2. Antithrombogenic Material Science: Clotting in bloodlines is a significant challenge during dialysis. Advanced coatings (such as heparin-grafted or fluoropolymer-grafted surfaces) are being applied to catheters, needles, and hemodialyzers to improve biocompatibility and minimize system clotting.
3. Eco-friendly Medical Consumables: In line with global sustainability initiatives, healthcare systems are seeking alternatives to traditional PVC-based consumables. The research and development of non-PVC, environmentally friendly polymer alloys is a major focus area for forward-looking factories.
Our AV fistula needles feature ultra-thin walls that maximize the inner lumen diameter, allowing high blood flow rates while reducing the external needle profile. Furthermore, our proprietary siliconization process ensures smooth skin and vessel penetration, minimizing trauma and blood cell shearing.
Yes. We offer fully customized OEM/ODM needle manufacturing. Customers can send engineering drawings or physical samples, and our specialized mold-making and engineering teams will produce prototypes and finished products tailored to those precise parameters.
All sterile medical devices undergo a validated Ethylene Oxide (EO) sterilization process in accordance with ISO 11135. Every batch is quarantined and tested for sterility, chemical residues, and endotoxin levels before being cleared for export.
Standard bulk orders typically take 30 to 45 days from deposit confirmation and sample approval. Lead times for new customized molds depend on the complexity of the design, with prototyping usually taking 3 to 4 weeks.
